Back to Search
CYNTHIA RASCH, MD
MD
Internal Medicine Physician
NPI: 1124075841Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
MD00031582(WA)
Research & Publications (20)
Setup uncertainties of anatomical sub-regions in head-and-neck cancer patients after offline CBCT guidance.
PMID 19306753·Int J Radiat Oncol Biol Phys·2009
8-other
First-year quality of life assessment of an intra-arterial (RADPLAT) versus intravenous chemoradiation phase III trial.
PMID 18972429·Head Neck·2009
3-trial
Molecular markers predict outcome in squamous cell carcinoma of the head and neck after concomitant cisplatin-based chemoradiation.
PMID 19253368·Int J Cancer·2009
8-other
Effectiveness of salvage selective and modified radical neck dissection for regional pathologic lymphadenopathy after chemoradiation.
PMID 19132716·Head Neck·2009
8-other
Risk factors for hearing loss in patients treated with intensity-modulated radiotherapy for head-and-neck tumors.
PMID 19135315·Int J Radiat Oncol Biol Phys·2009
8-other
Cisplatin-DNA adduct formation in patients treated with cisplatin-based chemoradiation: lack of correlation between normal tissues and primary tumor.
PMID 17639394·Cancer Chemother Pharmacol·2008
8-other
Impact of anatomical location on value of CT-PET co-registration for delineation of lung tumors.
PMID 17980511·Int J Radiat Oncol Biol Phys·2008
4-observational
Prognostic value of primary tumor volume after concurrent chemoradiation with daily low-dose cisplatin for advanced-stage head and neck carcinoma.
PMID 18642295·Head Neck·2008
8-other
Hearing loss due to concurrent daily low-dose cisplatin chemoradiation for locally advanced head and neck cancer.
PMID 18706728·Radiother Oncol·2008
8-other
Breast-conserving therapy: radiotherapy margins for breast tumor bed boost.
PMID 18755557·Int J Radiat Oncol Biol Phys·2008
8-other
99mTc Hynic-rh-Annexin V scintigraphy for in vivo imaging of apoptosis in patients with head and neck cancer treated with chemoradiotherapy.
PMID 17994297·Eur J Nucl Med Mol Imaging·2008
8-other
Parotid gland sparing IMRT for head and neck cancer improves xerostomia related quality of life.
PMID 19068126·Radiat Oncol·2008
8-other
Heterogeneity of gene expression profiles in head and neck cancer.
PMID 17615564·Head Neck·2007
8-other
Intensity-modulated vs. conformal radiotherapy of parotid gland tumors: potential impact on hearing loss.
PMID 17980823·Med Dosim·2007
4-observational
Genetic abnormalities associated with chemoradiation resistance of head and neck squamous cell carcinoma.
PMID 17671120·Clin Cancer Res·2007
8-other
Concurrent chemoradiation with daily low dose cisplatin for advanced stage head and neck carcinoma.
PMID 17445927·Radiother Oncol·2007
3-trial
Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis.
PMID 17418969·Int J Radiat Oncol Biol Phys·2007
8-other
Retrospective attenuation correction of PET data for radiotherapy planning using a free breathing CT.
PMID 17343940·Radiother Oncol·2007
8-other
Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer.
PMID 17704425·J Clin Oncol·2007
3-trial
Gene expression profiling to predict outcome after chemoradiation in head and neck cancer.
PMID 17931799·Int J Radiat Oncol Biol Phys·2007
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 401 W POPLAR ST, PHARMACY
WALLA WALLA, WA 99362 - Phone
- (509) 525-3320
Quick Facts
- NPI
- 1124075841
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile